| 000 | 01785 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517043842.0 | ||
| 264 | 0 | _c20160721 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep12616 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlingai, Seleeke | |
| 245 | 0 | 0 |
_aProtection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. _h[electronic resource] |
| 260 |
_bScientific reports _cJul 2015 |
||
| 300 |
_a12616 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 |
_aCross Reactions _ximmunology |
| 650 | 0 | 4 |
_aDengue _ximmunology |
| 650 | 0 | 4 |
_aDengue Virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNeutralization Tests _xmethods |
| 650 | 0 | 4 |
_aNucleic Acids _ximmunology |
| 650 | 0 | 4 | _aVero Cells |
| 650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
| 700 | 1 | _aPlummer, Emily M | |
| 700 | 1 | _aPatel, Ami | |
| 700 | 1 | _aShresta, Sujan | |
| 700 | 1 | _aMendoza, Janess M | |
| 700 | 1 | _aBroderick, Kate E | |
| 700 | 1 | _aSardesai, Niranjan Y | |
| 700 | 1 | _aMuthumani, Kar | |
| 700 | 1 | _aWeiner, David B | |
| 773 | 0 |
_tScientific reports _gvol. 5 _gp. 12616 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep12616 _zAvailable from publisher's website |
| 999 |
_c25117992 _d25117992 |
||